Masaki Ishida

Statistics

Publications

Citations

138

H-Index

Active since

2021

Affiliations

Kyoto Prefectural University of Medicine(Current)

Kyoto first Red Cross hospital

Japanese Red Cross Society Kyoto Daini Hospital

Osaka International Cancer Institute

Kanazawa University

Masaki Ishida is an author at Kyoto Prefectural University of Medicine specializing in non-small cell lung cancer therapy, oncology, and pharmacology.

ORCID

Publications per year

2021–2024

Publications

Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer

Yuki Katayama, Tadaaki Yamada, Keiko Tanimura et al. · npj Precision Oncology · 2023 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non−Small Cell Lung Cancer

Hayato Kawachi, Tadaaki Yamada, Motohiro Tamiya et al. · JAMA Network Open · 2023 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancer

Ryota Nakamura, Tadaaki Yamada, Shinsaku Tokuda et al. · Cancer Letters · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non‐small cell lung cancer

Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi et al. · Cancer Science · 2024 · 17 citations · Full text

Medicine, Molecular Genetics, Oncology +13

Impact of docetaxel plus ramucirumab in a second‐line setting after chemoimmunotherapy in patients with non‐small‐cell lung cancer: A retrospective study

Masaki Ishida, Kenji Morimoto, Tadaaki Yamada et al. · Thoracic Cancer · 2021 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

1–5 of 7